Viewing Study NCT04898036



Ignite Creation Date: 2024-05-06 @ 4:10 PM
Last Modification Date: 2024-10-26 @ 2:05 PM
Study NCT ID: NCT04898036
Status: WITHDRAWN
Last Update Posted: 2023-01-06
First Post: 2021-05-18

Brief Title: Phototherapy For Treatment Of Raynauds Phenomenon
Sponsor: University of Minnesota
Organization: University of Minnesota

Study Overview

Official Title: Phototherapy For Treatment Of Raynauds Phenomenon
Status: WITHDRAWN
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: no funding or staff
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To determine if blue light therapy can improve the symptoms of Raynauds phenomenon and provide parameters for ultimately designing commercial treatment devices an investigational stationary phototherapy unit was designed and built
Detailed Description: The purpose of this study is to test the efficacy of blue light phototherapy for the treatment of Raynauds phenomenon RP in human participants The specific aim is to see if phototherapy treatment applied to the hands will reduce the symptoms that RP participants experience This will be measured through the use of a visual analog scale VAS of both pain and numbness This study will also help to infer whether blue light phototherapy causes vasodilation through infrared thermal imaging of the hands and continuous measurement of skin temperature with a surface thermistor Together the visual analog scale VAS and infrared thermal imaging contribute to the objective of deducing whether blue light phototherapy can lead to reduced RP symptoms due to vasodilation of blood vessels

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None